CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biopharmaceutical company, announced today that Dr. Spyridon "Spyros" Papapetropoulos has joined as Executive Vice President, Research and Development and Chief Medical Officer. Dr. Papapetropoulos will lead Cavion’s research and development organization to advance therapies based on the company’s T-type calcium channel (Cav3) platform.
- Published: Monday, 12 June 2017 12:07
Astraea, a software startup in Charlottesville, is ready to take on the world — specifically, the detailed images of it captured by satellites.
“We are building a tool so people without Ph.D.s in data science can interrogate one of the biggest datasets ever,” said CEO Brendan Richardson. “They will use it in ways we would never think of on our own.”